Anti-IL31R/ IL31RA/ CRL monoclonal antibody

Anti-IL31R/ IL31RA/ CRL antibody for FACS & in-vivo assay

Target products collectionGo to IL31R/IL31RA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T84614-Ab-1/ GM-Tg-hg-T84614-Ab-2Anti-Human IL31R/IL31RA monoclonal antibodyHuman
GM-Tg-rg-T84614-Ab-1/ GM-Tg-rg-T84614-Ab-2Anti-Rat IL31R/IL31RA monoclonal antibodyRat
GM-Tg-mg-T84614-Ab-1/ GM-Tg-mg-T84614-Ab-2Anti-Mouse IL31R/IL31RA monoclonal antibodyMouse
GM-Tg-cynog-T84614-Ab-1/ GM-Tg-cynog-T84614-Ab-2Anti-Cynomolgus/ Rhesus macaque IL31R/IL31RA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T84614-Ab-1/ GM-Tg-felg-T84614-Ab-2Anti-Feline IL31R/IL31RA monoclonal antibodyFeline
GM-Tg-cang-T84614-Ab-1/ GM-Tg-cang-T84614-Ab-2Anti-Canine IL31R/IL31RA monoclonal antibodyCanine
GM-Tg-bovg-T84614-Ab-1/ GM-Tg-bovg-T84614-Ab-2Anti-Bovine IL31R/IL31RA monoclonal antibodyBovine
GM-Tg-equg-T84614-Ab-1/ GM-Tg-equg-T84614-Ab-2Anti-Equine IL31R/IL31RA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T84614-Ab-1/ GM-Tg-hg-T84614-Ab-2; GM-Tg-rg-T84614-Ab-1/ GM-Tg-rg-T84614-Ab-2;
GM-Tg-mg-T84614-Ab-1/ GM-Tg-mg-T84614-Ab-2; GM-Tg-cynog-T84614-Ab-1/ GM-Tg-cynog-T84614-Ab-2;
GM-Tg-felg-T84614-Ab-1/ GM-Tg-felg-T84614-Ab-2; GM-Tg-cang-T84614-Ab-1/ GM-Tg-cang-T84614-Ab-2;
GM-Tg-bovg-T84614-Ab-1/ GM-Tg-bovg-T84614-Ab-2; GM-Tg-equg-T84614-Ab-1/ GM-Tg-equg-T84614-Ab-2
Products NameAnti-IL31R/IL31RA monoclonal antibody
Formatmab
Target NameIL31R
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL31R benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-372Pre-Made Nemolizumab biosimilar, Whole mAb, Anti-IL31RA/IL31R Antibody: Anti-CRL/CRL3/GLM-R/GLMR/GPL/IL-31RA/PLCA2/PRO21384/hGLM-R/zcytoR17 therapeutic antibody
    Target AntigenProducts DevelopingMulti-species IL31R/ IL31RA/ CRL VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T84614-Ag-1interleukin 31 receptor A (IL31RA) protein


    Target information

    Target IDGM-T84614
    Target NameIL31R
    Gene ID133396,218624,688622,709719,487212,101095878,522636,100062017
    Gene Symbol and SynonymsCRL,CRL3,GLM-R,GLMR,GPL,hGLM-R,IL-31RA,IL31RA,NR10,PLCA2,PRO21384,zcytoR17
    Uniprot AccessionQ8NI17
    Uniprot Entry NameIL31R_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000164509
    Target ClassificationN/A

    The target: IL31R, gene name: IL31RA, also named as CRL, CRL3, GLM-R, GLMR, GPL, IL-31RA, PLCA2, PRO21384, hGLM-R. The protein encoded by this gene belongs to the type I cytokine receptor family. This receptor, with homology to gp130, is expressed on monocytes, and is involved in IL-31 signaling via activation of STAT-3 and STAT-5. It functions either as a monomer, or as part of a receptor complex with oncostatin M receptor (OSMR). Several alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jun 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.